Sathguru Webinar Series 2020
Sathguru Webinar Series-1
The webinar will focus on key IP related considerations in the context of life science investments. With perspectives covering depth of strategic IP management, legal considerations and pragmatic learnings from a venture that has traversed the investment journey, the panel will discuss criticality of Creating an IP portfolio that serves as a value enhancing business asset with strong competitive ring fencing; Capital efficient / accelerating strategies for IP access and co-creation; IP valuation and impact on transaction consideration, drivers for value enhancement; IP considerations for transaction structuring and IP due-diligence and housekeeping from a transaction perspective
Panelists
Pushpa Vijayaraghavan: Director & Practice Lead, Sathguru Management Consultants
Goutam Bhattacharyya : Partner & Head, Hyderabad Office, K&S Partners
Manjiri Bakre: Founder and CEO at OncoStem Diagnostics
[caldera_form_modal id=”CF5f1fe74edbe2f” type=”button”]Watch Now [/caldera_form_modal]
Sathguru Webinar Series-2
The webinar will discuss impact of the current crisis and response measures on healthcare delivery in India. Discretionary healthcare came to a near grounding halt due to the lockdown and is expected to rebound in a gradual manner while threat and fear of contagion persist. The webinar will discuss perspectives from leaders in the Indian healthcare delivery landscape on the rebound expected, how care delivery will evolve and financial/business implications.
Panelists
Sunil Thakur : MD – Quadria Capital
Sanjeev Vashista : MD & CEO – Pathkind Labs
Dr. Gurava Reddy : MD – Sunshine Group Hospitals
Dr. Pramod Gaddam : CEO – Fernandez Foundation
Moderator
Pushpa Vijayaraghavan: Director & Practice Lead, Sathguru Management Consultants
[caldera_form_modal id=”CF5f1fed7439b60″ type=”button”]Watch Now [/caldera_form_modal]
Sathguru Webinar Series-3
COVID-19 has had pervasive impact across economies and industry. While the pharma industry is not exception and has had to rapidly adapt, the impact has been less severe than most other industries. To discuss the business impact of COVID-19 and the recovery expected, we bring together a holistic panel of corporate leaders from the cross-section of Indian pharma landscape
Panelists
Chandru Chawla : EVP – Cipla
Dr Satyanarayana Chava : MD of Laurus Labs
Suresh Pattathil : India GM at Abbvie
Moderator
Pushpa Vijayaraghavan: Director & Practice Lead, Sathguru Management Consultants
[caldera_form_modal id=”CF5f2670e192841″ type=”button”]Watch Now [/caldera_form_modal]
Sathguru Webinar Series-4
Every section of the healthcare value chain is at the forefront in the current COVID-19 context. Healthcare delivery institutions have adapted to providing care under the new normal and are the lifeline of COVID-19 response measures. However, patient footfall outside of COVID care is drastically low and balance sheet stress is an impending reality.
Panelists
VT Bharadwaj : General Partner @ A91 Former Managing Director Sequoia Capital
Pushpa Vijayaraghavan: Director & Practice Lead, Sathguru Management Consultants
[caldera_form_modal id=”CF5f4e1792b8022″ type=”button”]Watch Now [/caldera_form_modal]